Back to results
TerminatedPhase 3

Spironolactone in the Treatment of Heart Failure

NCT04727073

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Medical University of Graz

Graz, Austria

+68 additional locations

View on ClinicalTrials.gov